期刊文献+

SLC22A18基因表达对胶质瘤细胞生物学特性的影响 被引量:9

Influence of SLC22A18 gene expression on the biological behaviors of glioma cells
原文传递
导出
摘要 目的观察SLC22A18基因表达对人胶质瘤U251细胞生物学特性的影响。方法U251细胞分别转染peDNA3.SLC22A18和peDNA3表达质粒后,筛选3个表达不同水平SLC22A18的U251克隆和2个不表达SLC22A18的U251克隆,研究SLC22A18蛋白表达水平对U251细胞黏附、迁移及聚集能力的影响。结果与不表达SLC22A18的U251细胞比较,表达SLC22A18的U251细胞在附着后1h和4h时的细胞黏附能力均显著增强,分别平均增强65.7%和26.5%(P〈0.01),而其细胞过河实验显示过河时间平均延长67.8%(P〈0.05),并且细胞迁移能力平均下降71.5%(P〈0.01)。同时,SLC22A18表达诱导显著的同源细胞聚集,聚集指数平均下降53.2%(P〈0.01)。结论SLC22A18蛋白表达显著抑制人胶质瘤U251细胞的恶性生物学特性。 Objective To study the effect of SLC22A18 gene expression on the biological behaviors of human glioma U251 cells. Methods Three U251 clones with different expression levels of SLC22A18 and two U251 clones without SLC22A18 expression after transfecting U251 cells with peDNA3. SLC22A18 and peDNA3 using lipofectin were chosen to study the effects of SLC22A18 gene expression on cell adhesion, motility and aggregation. Results Compared to the non-SLC22A18-expressing U251 cells, SLC22A18-ex- presing U251 cells indicated enhanced cell adhesion, and average 65.7% and 26. 5% increases in cell ad- hesion at 1 st and 4th h of the culture were observed (P 〈 0. 01 ), but the crossing-river time of SLC22A18- expresing U251 cells was averagely prolonged by 67. 8% (P 〈 0. 05 ) , and their motility was decreased by 71.5% (P〈 0. 01 ). At the same time, SLC22A18-expressing U251 cells demonstrated signifieantly homophilic aggregation, and aggregation index was decreased by 53.2% compared to the non-SLC22A18- expressing U251 cells (P 〈 0. 01 ). Conclusion SLC22A18 gene expression significantly suppresses the malignant biological behaviors of U251 glioma cells.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2011年第6期951-953,共3页 Chinese Journal of Experimental Surgery
基金 基金项目:国家自然科学基金资助项目(30901535)
关键词 胶质瘤 侵袭 生物学 Glioma Invasion Biology
  • 相关文献

参考文献3

二级参考文献15

  • 1桂贤,刘会敏.肿瘤多药耐药发生机制的研究进展[J].上海医学,2005,28(2):161-164. 被引量:25
  • 2吴珊,李玉林,王勇.肿瘤细胞浸润能力的体外实验研究及实际意义[J].白求恩医科大学学报,1995,21(3):249-251. 被引量:5
  • 3杨伯平,任瑞美,于金明.乳腺癌耐药蛋白的最新进展[J].中国现代医学杂志,2006,16(11):1678-1681. 被引量:3
  • 4Cooper PR, Snfilinich N J, Day CD, et al. Divergently transcribed overlapping genes expressed in liver and kidney and located in the 11 p15. 5 imprinted domain. Genomics, 1998,49:38-51.
  • 5Dao D, Dale F, Qian N. f, et al. IMPT1, an imprinted gene similar to polyspecific transporter and multi-drug resistance genes. Human Molecular Genetics, 1998,7:597-608.
  • 6Yamada HY, Gorbsky GJ. Tumor suppressor candidate TSSC5 is regulated by UbcH6 and a novel ubiquitin ligase RING105. Oncogen, 2006,25 : 1330-1339.
  • 7Tirona RG, Kim RB. Pharmacogenomics of organic anion-transporting polypeptides (OATP). Adv Drug Deliv Rev,2002,54 : 1343-1352.
  • 8Reece M, Prawitt D, Landers J, et al. Functional characterization of ORCTL2-an organic cation transporter expressed in the renal proximal tubules. FEBS Letters, 1998,433:245-250.
  • 9Eee Shi Z, Jain S, Kim IW, et al. Sipholenol A, a marine-derived sipholane triterpene,potently reverses P-glycoprotein ( ABCB1 ) -mediated muhidrug resistance in cancer cells. Cancer Sci,2007,98 : 1373- 1380.
  • 10Doyle LA, Yang W, Abruzzo LV, et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA, 1998,95 : 15665-15670.

共引文献26

同被引文献44

引证文献9

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部